eanNews - Page 124 of 282 - Stay up to date with Neurology in Europe

- Executive Page: New Congress Co-Hosting Plan, Upcoming Elections, and Membership Renewal
  
  October 9, 2025
- President’s Corner – October 2025
  
  October 8, 2025
- Research Paper of the Month: AI-driven reclassification of multiple sclerosis progression
  
  October 6, 2025
- Executive Page: New Opportunities and Resources to Strengthen EAN’s Scientific Community in 2025–2026
  
  September 4, 2025
- President’s Corner – September 2025
  
  September 4, 2025
- Research Paper of the Month: Lithium deficiency and the onset of Alzheimer’s disease
  
  September 4, 2025

Top Articles

Join Now for Bonus Months! Plus: October Renewal Discount and Special Benefit for Associate Members

October 1, 2025

Join us now and take advantage of bonus months. Active individual members enjoy October discount for renewals and associate members special a benefit!

EAN Associate Members Get Access to EAN Congress 2025 Content for October!

September 26, 2025

EAN Joins European Health Alliance on Alcohol, Co-Funded by EU/WHO Evidence into Action Alcohol

September 16, 2025

Revisit the Highlights of EAN 2025 in Our Congress Review eBook

July 24, 2025

European Huntington’s Association Biennial Conference 2025: Shaping Our Future Together

July 16, 2025

Latest Posts

Breaking news COVID-19 Research
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia

October 1, 2020

Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia
Breaking news COVID-19 Research
The impact of COVID-19 on epilepsy care: a survey of the American Epilepsy Society membership

October 1, 2020

The impact of COVID-19 on epilepsy care: a survey of the American Epilepsy Society membership
Breaking news COVID-19 Research
COVID-19 case fatality and Parkinson’s disease

October 1, 2020

COVID-19 case fatality and Parkinson’s disease
Breaking news COVID-19 Research
Neuro-ophthalmic manifestations of coronavirus disease 19

October 1, 2020

Neuro-ophthalmic manifestations of coronavirus disease 19
Breaking news COVID-19 Research
Risk factors for intracerebral hemorrhage in patients with COVID‐19

October 1, 2020

Risk factors for intracerebral hemorrhage in patients with COVID‐19
Breaking news COVID-19 Research
Multiple sclerosis and COVID‐19: how many are at risk?

October 1, 2020

Multiple sclerosis and COVID‐19: how many are at risk?
Breaking news COVID-19 Research
Thrombolysis and bridging therapy in patients with acute ischemic stroke and Covid‐19

October 1, 2020

Thrombolysis and bridging therapy in patients with acute ischemic stroke and Covid‐19
Breaking news COVID-19 Research
Increased risk of acute stroke among patients with severe COVID‐19: a multicenter study and meta‐analysis

October 1, 2020

Increased risk of acute stroke among patients with severe COVID‐19: a multicenter study and meta‐analysis
Breaking news COVID-19 Research
Loss of smell in COVID-19 patients: MRI data reveals a transient edema of the olfactory clefts

October 1, 2020

Loss of smell in COVID-19 patients: MRI data reveals a transient edema of the olfactory clefts
Breaking news COVID-19 Research
Stroke risk, phenotypes, and death in COVID-19: Systematic review and newly reported cases

October 1, 2020

Stroke risk, phenotypes, and death in COVID-19: Systematic review and newly reported cases
Breaking news COVID-19
Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome studies in 8 stuporous and comatose patients

October 1, 2020

Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome studies in 8 stuporous and comatose patients
Breaking news COVID-19 Research
Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong

October 1, 2020

Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong
Breaking news COVID-19 Research
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

October 1, 2020

Auto-antibodies against type I IFNs in patients with life-threatening COVID-19
Breaking news COVID-19 Research
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

October 1, 2020

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Breaking news COVID-19 Research
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis

October 1, 2020

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis

Newer Posts

Older Posts